Long-term risk of breast cancer in women with fibroadenoma.

BACKGROUND Fibroadenomas are benign breast tumors that are commonly diagnosed in young women and are associated with a slight increase in the risk of breast cancer. These lesions vary considerably in their histologic characteristics. We assessed the correlation between the histologic features of fibroadenomas and the risk of subsequent breast cancer. METHODS We conducted a retrospective cohort study of a consecutive series of patients with fibroadenoma diagnosed between 1950 and 1968. Follow-up data were obtained for 1835 patients (90 percent of those eligible). Fibroadenomas with cysts, sclerosing adenosis, epithelial calcifications, or papillary apocrine changes were classified as complex. The rate of subsequent breast cancer among the patients was compared with the rates in two control groups, women listed in the Connecticut Tumor Registry and women chosen from among the patients' sisters-in-law. RESULTS The risk of invasive breast cancer was 2.17 times higher among the patients with fibroadenoma than among the controls (95 percent confidence interval, 1.5 to 3.2). The relative risk increased to 3.10 among patients with complex fibroadenomas (95 percent confidence interval, 1.9 to 5.1) and remained elevated for decades after diagnosis. Patients with benign proliferative disease in the parenchyma adjacent to the fibroadenoma had a relative risk of 3.88 (95 percent confidence interval, 2.1 to 7.3). Patients with a family history of breast cancer in whom complex fibroadenoma was diagnosed had a relative risk of 3.72, as compared with controls with a family history (95 percent confidence interval, 1.4 to 10). Two thirds of the patients had noncomplex fibroadenomas and no family history of breast cancer and did not have an increased risk. CONCLUSIONS Fibroadenoma is a long-term risk factor for breast cancer. The risk is increased in women with complex fibroadenomas, proliferative disease, or a family history of breast cancer.

[1]  P. McCullagh,et al.  Generalized Linear Models, 2nd Edn. , 1990 .

[2]  N. E. Breslow Statistical Methods in Cancer Research , 1986 .

[3]  A. V. Peterson,et al.  Risk of breast cancer in women with benign breast disease. , 1980, Journal of the National Cancer Institute.

[4]  David L. Page,et al.  Diagnostic Histopathology of the Breast , 1988 .

[5]  W. Dupont,et al.  Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. , 1989, Human pathology.

[6]  P. Taylor,et al.  A prospective study of the development of breast cancer in 16,692 women with benign breast disease. , 1988, American journal of epidemiology.

[7]  P. Wingo,et al.  Histologic types of benign breast disease and the risk for breast cancer , 1992, Cancer.

[8]  L. Brinton,et al.  Breast cancer risk associated with proliferative breast disease and atypical hyperplasia , 1993, Cancer.

[9]  W D Dupont,et al.  Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.

[10]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[11]  M. Moskowitz,et al.  Proliferative disorders of the breast as risk factors for breast cancer in a self-selected screened population: pathologic markers. , 1980, Radiology.

[12]  S. Bianchi,et al.  Benign breast disease and breast cancer: A case‐control study in a cohort in italy , 1991, International journal of cancer.

[13]  R. Hiatt,et al.  Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. , 1992, American journal of epidemiology.

[14]  D. Page,et al.  Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. , 1992, Human pathology.